The Dynamin-dependent, Arrestin-independent Internalization of 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptors Reveals Differential Sorting of Arrestins and 5-HT2A Receptors during Endocytosis
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
5-Hydroxytryptamine 2A (5-HT2A) receptors, a major site of action of clozapine and other atypical antipsychotic medications, are, paradoxically, internalized in vitro and in vivo by antagonists and agonists. The mechanisms responsible for this paradoxical regulation of 5-HT2A receptors are unknown. In this study, the arrestin and dynamin dependences of agonist- and antagonist-mediated internalization were investigated in live cells using green fluorescent protein (GFP)-tagged 5-HT2A receptors (SR2-GFP). Preliminary experiments indicated that GFP tagging of 5-HT2A receptors had no effect on either the binding affinities of several ligands or agonist efficacy. Likewise, both the native receptor and SR2-GFP were internalized via endosomes in vitro. Experiments with a dynamin dominant-negative mutant (dynamin K44A) demonstrated that both agonist- and antagonist-induced internalization were dynamin-dependent. By contrast, both the agonist- and antagonist-induced internalization of SR2-GFP were insensitive to three different arrestin (Arr) dominant-negative mutants (Arr-2 V53D, Arr-2-(319-418), and Arr-3-(284-409)). Interestingly, 5-HT2A receptor activation by agonists, but not antagonists, induced greater Arr-3 than Arr-2 translocation to the plasma membrane. Importantly, the agonist-induced internalization of 5-HT2A receptors was accompanied by differential sorting of Arr-2, Arr-3, and 5-HT2A receptors into distinct plasma membrane and intracellular compartments. The agonist-induced redistribution of Arr-2 and Arr-3 into intracellular vesicles and plasma membrane compartments distinct from those involved in 5-HT2A receptor internalization implies novel roles for Arr-2 and Arr-3 independent of 5-HT2A receptor internalization and desensitization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,384
Self-citationMeltzer, H. Y., Matsubara, S., & Lee, J. C. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20710-8 · Cited by 1,349
Role of β-Arrestin in Mediating Agonist-Promoted G Protein-Coupled Receptor Internalization
Ferguson, S. S. G., Downey, W. E., Colapietro, A.-M., Barak, L. S., Ménard, L., & Caron, M. G. (1996) · Science · doi:10.1126/science.271.5247.363 · Cited by 972
Oakley, R. H., Laporte, S. A., Holt, J. A., Caron, M. G., & Barak, L. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910348199 · Cited by 882
Long-Term Antidepressant Treatment Decreases Spiroperidol-Labeled Serotonin Receptor Binding
Peroutka, S. J., & Snyder, S. H. (1980) · Science · doi:10.1126/science.6251550 · Cited by 832
AGHAJANIAN, G. K., & MAREK, G. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00051-8 · Cited by 514
von Zastrow, M., & Kobilka, B. K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50762-1 · Cited by 459
Laporte, S. A., Oakley, R. H., Holt, J. A., Barak, L. S., & Caron, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002581200 · Cited by 401
Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex
Willins, D. L., Deutch, A. Y., & Roth, B. L. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199709)27:1<79::aid-syn8>3.0.co;2-a · Cited by 345
Self-citationKrupnick, J. G., Goodman, O. B., Keen, J. H., & Benovic, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.15011 · Cited by 303
Self-citationZhang, J., Barak, L. S., Winkler, K. E., Caron, M. G., & Ferguson, S. S. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.27005 · Cited by 238
Role of Phosphorylation in Agonist-promoted β2-Adrenergic Receptor Sequestration
Ferguson, S. S. G., Ménard, L., Barak, L. S., Koch, W. J., Colapietro, A.-M., & Caron, M. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24782 · Cited by 216
Gagnon, A. W., Kallal, L., & Benovic, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6976 · Cited by 214
Self-citationModulation of the Arrestin-Clathrin Interaction in Cells
Krupnick, J. G., Santini, F., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32507 · Cited by 202
Self-citationWillins, D. L., Berry, S. A., Alsayegh, L., Backstrom, J. R., Sanders-Bush, E., Friedman, L., & Roth, B. L. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00653-8 · Cited by 171
Self-citationGelber, E. I., Kroeze, W. K., Roth, B. L., Gray, J. A., Sinar, C. A., Hyde, E. G., Gurevich, V. V., Benovic, J., & Roth, B. L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722206.x · Cited by 116
Self-citationSerotonin 5-HT2A Receptors: Molecular Biology and Mechanisms of Regulation
Roth, B. L., Berry, S. A., Kroeze, W. K., Willins, D. L., & Kristiansen, K. (1998) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v12.i4.30 · Cited by 113
Self-citationBerry, S. A., Shah, M. C., Khan, N., & Roth, B. L. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09230-2 · Cited by 110
Self-citationEgan, C. T., Herrick-Davis, K., & Teitler, M. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37560-3 · Cited by 96
Barak, L. S., Warabi, K., Feng, X., Caron, M. G., & Kwatra, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7565 · Cited by 86
Orsini, M. J., & Benovic, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34616 · Cited by 73
Self-citationRoth, B. L., & Ciaranello, R. D. (1991) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(91)90093-w · Cited by 68
Self-citationRoth, B. L., Willins, D. L., & Kroeze, W. K. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00067-2 · Cited by 65
Self-citationSerotonergic Antagonist Effects on Trafficking of Serotonin 5‐HT2A Receptors in Vitro and in Vivoa
Willins, D. L., Alsayegh, L., BERRY, S. A., Backstrom, J. R., Sanders‐Bush, E., Friedman, L., KHAN, N., & Roth, B. L. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10182.x · Cited by 59
Self-citation
Cited by
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationAripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 968
Self-citationThe neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Claing, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00023-5 · Cited by 519
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Metadata
- Authors
- Bhatnagar, A., Willins, D. L., Gray, J. A., Woods, J., Benovic, J. L., & Roth, B. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 276
- Issue
- 11
- Pages
- 8269-8277
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087773298
- Cited by
- 163
- References
- 24
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.